Home
/

What is an Indirect Bilirubin Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

Indirect (unconjugated) bilirubin is the fat-soluble, albumin-bound pigment produced when macrophages break down hemoglobin before the liver conjugates it. Elevated levels may help support assessment of hemolysis, Gilbert syndrome, or newborn jaundice risk. It is interpreted alongside direct bilirubin, LDH, haptoglobin, and reticulocytes to distinguish hemolytic from hepatic-processing causes.

Read more →
Table of contents

The unconjugated, albumin-bound fraction before the liver acts

Indirect bilirubin is the form of bilirubin circulating before the liver modifies it. Bilirubin is a yellow pigment created when old red blood cells are dismantled; hemoglobin's heme ring is opened to biliverdin, then reduced to bilirubin (unconjugated bilirubin). This fat‑soluble molecule leaves the spleen and other tissues attached to albumin and travels in the bloodstream to the liver. "Indirect" refers to this unprocessed, albumin‑bound, water‑insoluble fraction that has not yet been linked to glucuronic acid by the liver's UGT1A1 enzyme (conjugation).

Measuring indirect bilirubin reflects the balance between how fast the body is breaking down red cells and how effectively the liver is taking up and conjugating bilirubin. It captures upstream steps in heme recycling and hepatic handling, rather than bile flow and excretion. In the body, bilirubin also acts as a circulating antioxidant, but it must be conjugated to become water‑soluble and leave the body in bile (direct, conjugated bilirubin). Thus, the indirect fraction primarily signals production and delivery of bilirubin to the liver, offering a window into red cell turnover (hemolysis) and the liver's uptake and conjugation capacity.

A signal that links red-cell turnover to liver uptake

Indirect (unconjugated) bilirubin is the fat‑soluble pigment released when red blood cells are broken down. It travels bound to albumin to the liver, where it is conjugated and made water‑soluble. Measuring the indirect fraction (calculated as total minus direct) shows how much bilirubin is being produced versus how well the liver takes it up and conjugates it. Most healthy results fall in a narrow range, with "within reference ranges" usually in the low‑to‑middle portion of normal.

It tracks the balance between heme turnover, liver uptake/conjugation capacity, and albumin transport. At a systems level it touches oxygen-carrying cell renewal, hepatic metabolic workload, and antioxidant tone, with extremes affecting energy, skin/eye color (jaundice), and—mainly in newborns—neurologic safety.

Hemolysis versus a UGT1A1 conjugation issue

When the indirect value is on the low side, it generally signals low heme turnover and efficient hepatic handling. This is usually asymptomatic and not clinically important. Mildly lower levels can also reflect dilutional effects (for example, in late pregnancy) or simple analytic variation.

Low values usually reflect low heme breakdown and efficient hepatic processing. They are common after meals and in pregnancy due to dilution and increased clearance, and are typically asymptomatic. Women and during pregnancy tend to run lower than men and nonpregnant adults.

Being in range suggests balanced red cell turnover and normal liver uptake and conjugation, with stable bile pigment handling and no evidence of hemolysis. There is no single "most appropriate" point; in healthy adults values commonly sit in the lower-to-middle part of the reference interval.

When the indirect value is higher, it points to either increased production or reduced conjugation. Extra production arises with hemolysis or large bruises being reabsorbed; people may notice fatigue, pallor, shortness of breath, or an enlarged spleen. Reduced conjugation is common in Gilbert syndrome—a benign, intermittent elevation more often seen in men and triggered by fasting or illness—and rare in Crigler‑Najjar. Jaundice (yellow eyes/skin) can appear, but urine typically stays normal in color because unconjugated bilirubin is not excreted in urine. In newborns, high indirect bilirubin is common; very high levels risk neurologic injury.

High values usually reflect increased production (hemolysis, large bruises, ineffective erythropoiesis), reduced hepatic uptake, or reduced conjugation (for example, Gilbert syndrome or UGT1A1 inhibition). Levels can rise transiently with fasting, illness, or vigorous exercise. Adults may notice scleral icterus or mild jaundice; hemolysis may add fatigue from anemia. Newborns often have high indirect bilirubin; very high levels can be neurotoxic.

Calculation, sample handling, and drug effects

Indirect bilirubin is often calculated as total minus direct, so assay differences and sample handling (light exposure, timing, fasting) matter. Medications such as atazanavir, indinavir, or rifampin can raise indirect bilirubin. Age, sex, and pregnancy alter typical values.

From blood breakdown to hepatic processing in one fraction

The indirect fraction links blood cell turnover with liver processing. Interpreted alongside direct bilirubin, AST/ALT, LDH, haptoglobin, and reticulocytes, it helps separate blood‑based from liver‑processing causes, informs risks like pigment gallstones in chronic hemolysis, and frames newborn jaundice safety.

FAQs

Bilirubin, Indirect testing measures the unconjugated fraction of bilirubin in blood to reflect red blood cell turnover and the liver’s uptake/conjugation capacity.

Indirect (unconjugated) bilirubin is fat-soluble and albumin-bound before liver processing; direct (conjugated) bilirubin is water-soluble after UGT1A1 conjugation and ready for excretion.

Frequency depends on goals and context. Establishing a baseline and retesting with changes in training, illness, fasting, medication use, or symptoms can clarify trends.

Hemolysis, ineffective red blood cell production (such as with B12 or folate deficiency), reduced UGT1A1 activity (for example Gilbert syndrome), certain medications, fasting, acute illness, heavy training, and dehydration can increase levels.

Lower values often reflect lower heme turnover and are typically benign. Interpretation is most useful alongside total/direct bilirubin and a CBC.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Fevery, J. (2008). Bilirubin in clinical practice: A review. Liver International, 28(5), 592-605. https://doi.org/10.1111/j.1478-3231.2008.01716.x
  2. Vitek, L., Hinds, T. D., Stec, D. E., & Tiribelli, C. (2023). The physiology of bilirubin: Health and disease equilibrium. Trends in Molecular Medicine, 29(4), 315-328. https://doi.org/10.1016/j.molmed.2023.01.007
  3. King, D., & Armstrong, M. J. (2023). Gilbert syndrome. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK470200/
  4. Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987). Bilirubin is an antioxidant of possible physiological importance. Science, 235(4792), 1043-1046. https://doi.org/10.1126/science.3029864
  5. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG clinical guideline: Evaluation of abnormal liver chemistries. The American Journal of Gastroenterology, 112(1), 18-35. https://doi.org/10.1038/ajg.2016.517

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey